Elanco Animal Health Incorporated (ELAN) on Monday said the U.S. Food and Drug Administration (FDA) has approved label expansions for two of its leading canine prescription parasiticides, Credelio Quattro and Credelio.
The updated labels now include prevention of Lyme disease, achieved through the killing of black-legged ticks, as well as the treatment and control of longhorned tick infestations.
According to the Companion Animal Parasite Council tracker, more than 422,000 cases of Lyme disease in dogs have been reported so far this year, exceeding the total annual cases recorded in 2019.
For comments and feedback contact: editorial@rttnews.com
Business News
December 26, 2025 08:42 ET Third quarter economic growth data from some major economies including the U.S. were the main news in this holiday shortened week. GDP growth and industrial production data from the U.S. helped to boost morale, while the consumer confidence survey results were less upbeat. In Europe, the quarterly economic growth data from the U.K. drew attention, while the minutes of the Australian central bank’s latest policy session was in focus in Asia.